Skip to content
OpenlyPages is a blog where writers share honest stories, l…

Zimbabwe Turns Down ‘One-Sided’ American Healthcare Assistance Package Due to Data Fears

Medical funding illustration
The offered US financial assistance was intended for programmes for HIV/Aids treatment and prevention, tuberculosis, and malarial diseases.

Zimbabwe has declined a major US health deal worth 367 million US dollars (272 million pounds) spanning five years because of the United States' request for confidential information.

This move was revealed after a government memo dated December was leaked, revealing that President Emmerson Mnangagwa deemed the agreement was "skewed".

A government spokesman has since clarified that the US was seeking genetic material for research and profit but refused to guarantee the resulting advantages from any future treatments.

"We will now turn to the difficult and regrettable process of ending our health assistance in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont in a statement.

The US Embassy noted the United States had provided over $1.9bn for health programmes to Zimbabwe during the past twenty years.

A doctors' association in Zimbabwe has appealed for more negotiations to reach a deal acceptable to all parties so the nation's critical HIV programme can be sustained.

Wider Background

Zimbabwe's decision comes after a comparable situation in neighbouring Kenya, where a court halted a related deal with the US following legal challenges were raised about the security of citizens' health data.

Since returning to the presidency recently, US President Donald Trump has drastically cut foreign aid and closed the key foreign aid agency.

The agency had administered aid for the US government, but Trump stated its spending was "wasteful" and his administration was seeking government-to-government deals to boost openness and responsibility.

As per reports, Sixteen nations in Africa have to date signed similar health pacts, constituting over $18.3bn in new funding.

Details of the Declined Agreement

The money for Zimbabwe would have funded "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".

"We are confident this cooperation might have yielded extraordinary benefits for the people of Zimbabwe, especially the 1.2 million men, women and children currently receiving antiretroviral therapy through US-supported initiatives," Tremont said.

However, official spokesman Nick Mangwana maintained the arrangement was "unequal".

"The proposal required Zimbabwe to surrender its genetic material and health information for a long time, without any equivalent assurance of access to any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that might result from that provided information," he stated.

"Put simply, our nation would supply the raw materials for medical research with no certainty that the end products would be accessible to our citizens if a new pandemic arise."

Sovereignty and International Frameworks

He also said that the US's withdrawal from the global health body and its pursuit of one-on-one deals were undermining structures previously set up through the international organization.

Mangwana gave as an example its Pathogen Access and Benefit Sharing scheme designed to deal with potential pandemics.

"This mechanism is designed to guarantee that when a country provides its data, the resulting advantages – such as vaccines and treatments – are distributed fairly, not monopolised solely by those with the funds to create them."

Zimbabwe's reservations over the US deal "must not be interpreted as hostility towards the US," Mangwana stressed.

"We welcome ongoing discussions with our American counterparts on how subsequent collaboration might be arranged in a way that honours the independence and interests of each country."

Health Experts Response

Medical experts said it understood the official position, but urged that negotiations must proceed since a large portion of the country's Aids initiatives relied on international support.

"If specific concerns exist, including those relating to information security or agreement terms, these can frequently be addressed via technical clarification and negotiated safeguards," the group commented.

The halted deal emphasises the ongoing tensions between receiving crucial foreign assistance and protecting a country's data in an increasingly data-driven world.

The writer

Jennifer Phillips

Maya Chen is a freelance writer and digital storyteller passionate about exploring human connections through personal narratives and cultural insights.

OpenlyPages

Type to search articles.